SCHEMBL10041787

SCHEMBL10041787

O=[N+]([O-])c1cccc(OCO)c1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.60
CHRNA4 P43681 2/20 0.60
TSHR P16473 2/20 0.55
LMNA P02545 1/20 0.55
MAOB P27338 1/20 0.52
ALDH1A1 P00352 3/20 0.52
ALOX15 P16050 1/20 0.52
CHRNB4 P30926 1/20 0.51
CHRNA3 P32297 1/20 0.51
F2 P00734 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
GRM5 P41594 1/20 0.49
CES2 O00748 1/20 0.49
CES1 P23141 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77341 0.86 CHRNB2 (0.66) CHRNB2CHRNA4TSHRLMNAMAOB
SCHEMBL15498199 0.85 CHRNB2 (0.73) CHRNB2CHRNA4TSHRLMNAMAOB
SCHEMBL16178929 0.85 CHRNB2 (0.64) CHRNB2CHRNA4TSHRLMNAMAOB
SCHEMBL29832812 0.85 CHRNB2 (0.64) CHRNB2CHRNA4TSHRLMNAMAOB
SCHEMBL5523744 0.85 CHRNB2 (0.64) CHRNB2CHRNA4TSHRLMNAMAOB
Hydrochloric Acid SCHEMBL10551164 0.84 CHRNB2 (0.62) CHRNB2CHRNA4TSHRLMNAMAOB
Hydrochloric Acid SCHEMBL10551171 0.84 CHRNB2 (0.62) CHRNB2CHRNA4TSHRLMNAMAOB
Hydrochloric Acid SCHEMBL10551173 0.84 CHRNB2 (0.62) CHRNB2CHRNA4TSHRLMNAMAOB
SCHEMBL5518334 0.83 CHRNB2 (0.62) CHRNB2CHRNA4TSHRLMNAMAOB
SCHEMBL31087898 0.83 CHRNB2 (0.62) CHRNB2CHRNA4TSHRLMNAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012042541-A2 METHOD FOR PREDICTING AND MODELING ANTI-PSYCHOTIC ACTIVITY USING VIRTUAL SCREENING MODEL COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-04-05 WO disclosed